{"data":{"id":"us/21-cfr-50.50","jurisdiction":"us","citation":"21 CFR 50.50","heading":"IRB duties.","body":"In addition to other responsibilities assigned to IRBs under this part and part 56 of this chapter, each IRB must review clinical investigations involving children as subjects covered by this subpart D and approve only those clinical investigations that satisfy the criteria described in § 50.51, § 50.52, or § 50.53 and the conditions of all other applicable sections of this subpart D.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER A—GENERAL","PART 50—PROTECTION OF HUMAN SUBJECTS","Subpart D—Additional Safeguards for Children in Clinical Investigations"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"456bc988c6d2220318e2b2d128587ef6a24fab3f7e41356ab7bfa61c07c00ba9","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-50.27","next":"us/21-cfr-50.51"},"notice":"GroundRules: Original legal text. Not legal advice."}